Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Navigating Breast Cancer Survivorship: Sustaining the Good News

      August 30, 2012
      By Ann McCue, RN, BSN, OCNA®
      Robert Fisher, MD
      Feature
      Article
      Oncology Nursing NewsAugust 2012
      Volume 6
      Issue 5

      Forty years after the declaration of war on cancer, one of the most profound shifts in cancer care today is a new focus on treating those living beyond cancer, as well as those living with cancer.

      Forty years after the declaration of war on cancer, one of the most profound shifts in cancer care today is a new focus on treating those living beyond cancer, as well as those living with cancer.1 We celebrate the news that there are more than 2.6 million people in the United States who have a history of breast cancer, yet are alive today.2 Oncology professionals, including nurse navigators, must address the specific needs of breast cancer survivors as their numbers continue to grow. In order for the oncology care community to sustain excellent outcomes for these survivors, there are several important questions to consider:

      Will medical oncologists continue to provide long-term breast cancer follow-up care?

      A recent survey found that 91% of breast cancer patients expect their oncologists to direct their follow-up care. Over the past two years, the American College of Surgeons and the Institute of Medicine have released reports that predict a severe shortage of medical oncologists (MOs) and other oncology-related healthcare personnel over the next 10-20 years.3 The expected shortage and ongoing changes to insurance reimbursement models are two factors that may accelerate the transition of breast cancer follow-up care from oncology specialists to primary care providers (PCPs). It is imperative that PCPs receive the support and education they need in order to provide safe and effective care during this transition.

      Are primary care physicians ready to treat breast cancer survivors?

      A nationwide study of barriers between PCPs and MOs revealed several clear themes. Cosponsored by the National Cancer Institute and the American Cancer Society, the Survey of Physician Attitudes Regarding the Care of Cancer Survivors was returned by 1072 PCPs and 1130 MOs providing care to breast and colon cancer survivors, a 57% response rate.4 PCPs were more likely than MOs to report ordering tests or treatments primarily as malpractice protection, being concerned about missing care, and lacking adequate training to manage patient problems. MOs were more likely than PCPs to report concerns about duplicated care. They also exhibited less confidence in PCPs’ skills to manage breast cancer than the PCPs did themselves. These results highlight the need for greater PCP support and training in breast cancer followup care, and the need for oncologists to promote and support that care by providing thorough treatment summaries and survivorship care plans.

      How will breast cancer follow-up care be supported?

      National standards are being discussed but are far from being finalized, so it is vital that evidence-based information about breast cancer follow-up care best practices is available to all stakeholders. In the fall of 2011, medical oncologist Robert Fisher, MD, formed a nonprofit organization to accomplish this very goal, as expressed in its mission statement: “The Pink Ribbon Survivors Network exists with the dual purpose of serving the needs of breast cancer survivors and the needs of health care professionals that care for breast cancer survivors.”5 The website offers a comprehensive online library that provides information for three primary groups: PCPs, survivors, and oncology professionals, including oncology nurse navigators (ONNs). These groups are all represented on the board.

      Living Beyond Breast Cancer

      In September 2011, the LIVESTRONG organization sponsored a meeting in Washington, DC, that brought together 150 community leaders, cancer experts, cancer survivors, and their advocates to identify the essential elements of survivorship care delivery. One of the five elements that received unanimous consensus was having a “strategy which addresses care coordination with primary care physicians and primary oncologists.”6 As plans evolve to provide support for breast cancer survivors throughout their lives, oncology nurse navigators must stay informed about the process and know how to access resources that will help make this goal a reality.

      References

      1. MD Anderson Cancer Center. Stages of Cancer Survivorship. MD Anderson Cancer Center website. http://www.mdanderson.org/patient-and-cancerinformation/cancer-information/cancer-topics/survivorship/stages-ofcancer-survivorship/index.html. Accessed January 2, 2011.
      2. American Cancer Society. What are the key statistics about breast cancer? ACR website. http://goo.gl/ucpmb. Updated June 11, 2012. Accessed Aug. 8, 2012.
      3. Debono D. Coping With the Oncology Workforce Shortage: Transitioning Oncology Follow-Up Care to Primary Care Providers. J Oncol Pract. 2010;6(4)203-205.
      4. Potosky AL, Han PKJ, Rowland J, et al. Differences Between Primary Care Physicians’ and Oncologists’ Knowledge, Attitudes and Practices Regarding the Care of Cancer Survivors. J Gen Intern Med. 2011; 26(12);1403-1410.
      5. Pink Ribbon Survivors Network. Our Mission. Pink Ribbon Survivors Network website. http://goo.gl/1fwfW. Accessed January 2, 2012.
      6. Rechis R, Beckjord EB, Arvey SR, et al. The Essential Elements of Survivorship Care: A Livestrong Brief. Livestrong website. https://livestrong.org/pdfs/3-0/EssentialElementsBrief. Published December 2011. Accessed January 3, 2011.
      Articles in this issue

      Squamous Cell Carcinoma of the Anus During Pregnancy
      Navigating Breast Cancer Survivorship: Sustaining the Good News
      Navigating Breast Cancer Survivorship: Sustaining the Good News
      ASCO Offers Resources for You and Your Patients

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      3 experts in this video
      3 experts in this video
      3 experts in this video
      3 experts in this video
      3 experts in this video
      3 experts in this video
      Image of a woman with gray hair on a light blue background
      Photo of a man wearing scrubs in front of a blue background
      Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
      Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
      Related Content

      Photo of an APP talking to and empowering a patient

      Case Study: Bridging the Gap for Patients With Metastatic CRC

      Randi Kihnel, MSN, APRN, ACCNS-AG
      June 13th 2025
      Article

      Advanced practice providers have the opportunity to instill hope in patients through education and personalized care.


      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      October 2nd 2023
      Podcast

      Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.


      Anatomical graphic of a person with a breast tumor

      PROs Higher For Imlunestrant With/Without Abemaciclib in ER+, HER2– BC

      Tim Cortese
      June 3rd 2025
      Article

      Treatment with imlunestrant was especially impactful to quality of life and global health status for patients with ESR1 mutations.


      The Vitals

      Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

      Lindsay Fischer
      January 16th 2023
      Podcast

      Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.


      Illustration of two people in lab coats using scientific instruments with a breast icon in the background

      Camizestrant/CDK4/6 Inhibition Boosts PFS in ESR1+ Advanced Breast Cancer

      Caroline Seymour
      June 2nd 2025
      Article

      Camizestrant plus CDK4/6 inhibition improved PFS vs standard care in patients with ER+/HER2– advanced breast cancer and emergent ESR1 mutations.


      Line illustration of a breast

      Sacituzumab Govitecan/Pembrolizumab Backed as New SOC in PD-L1+ TNBC

      Kristi Rosa
      May 31st 2025
      Article

      Sacituzumab govitecan/pembrolizumab in the first line lengthened PFS vs chemotherapy/pembrolizumab in PD-L1+ metastatic triple-negative breast cancer.

      Related Content

      Photo of an APP talking to and empowering a patient

      Case Study: Bridging the Gap for Patients With Metastatic CRC

      Randi Kihnel, MSN, APRN, ACCNS-AG
      June 13th 2025
      Article

      Advanced practice providers have the opportunity to instill hope in patients through education and personalized care.


      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      October 2nd 2023
      Podcast

      Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.


      Anatomical graphic of a person with a breast tumor

      PROs Higher For Imlunestrant With/Without Abemaciclib in ER+, HER2– BC

      Tim Cortese
      June 3rd 2025
      Article

      Treatment with imlunestrant was especially impactful to quality of life and global health status for patients with ESR1 mutations.


      The Vitals

      Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

      Lindsay Fischer
      January 16th 2023
      Podcast

      Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.


      Illustration of two people in lab coats using scientific instruments with a breast icon in the background

      Camizestrant/CDK4/6 Inhibition Boosts PFS in ESR1+ Advanced Breast Cancer

      Caroline Seymour
      June 2nd 2025
      Article

      Camizestrant plus CDK4/6 inhibition improved PFS vs standard care in patients with ER+/HER2– advanced breast cancer and emergent ESR1 mutations.


      Line illustration of a breast

      Sacituzumab Govitecan/Pembrolizumab Backed as New SOC in PD-L1+ TNBC

      Kristi Rosa
      May 31st 2025
      Article

      Sacituzumab govitecan/pembrolizumab in the first line lengthened PFS vs chemotherapy/pembrolizumab in PD-L1+ metastatic triple-negative breast cancer.

      Latest Conference Coverage

      Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care

      T-DXd PFS Benefit Significant Across HR+, HER2-Low Breast Cancer Mutations

      AI Tool May Predict Response, Resistance in Advanced RCC

      Olanzapine May Reduce Nausea, Vomiting From Radiation

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.